Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
INKT — MiNK Therapeutics, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 15, 2026
REVENUE
$0
EPS
-$0.57 -3.6%
FREE CASH FLOW
-$1.7M +16.5%

No summary has been written for this call yet.